Overexpression of RANK and M-CSFR in Monocytes of G551D-Bearing Patients with Cystic Fibrosis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:198 |
|---|---|
| Enthalten in: |
American journal of respiratory and critical care medicine - 198(2018), 7 vom: 01. Okt., Seite 968-970 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Velard, Frédéric [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 11.09.2019 Date Revised 30.03.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1164/rccm.201803-0415LE |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM285835548 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM285835548 | ||
| 003 | DE-627 | ||
| 005 | 20231225050324.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1164/rccm.201803-0415LE |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0952.xml |
| 035 | |a (DE-627)NLM285835548 | ||
| 035 | |a (NLM)29940131 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Velard, Frédéric |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Overexpression of RANK and M-CSFR in Monocytes of G551D-Bearing Patients with Cystic Fibrosis |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.09.2019 | ||
| 500 | |a Date Revised 30.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Aminophenols |2 NLM | |
| 650 | 7 | |a Chloride Channel Agonists |2 NLM | |
| 650 | 7 | |a Quinolones |2 NLM | |
| 650 | 7 | |a Receptor Activator of Nuclear Factor-kappa B |2 NLM | |
| 650 | 7 | |a TNFRSF11A protein, human |2 NLM | |
| 650 | 7 | |a Cystic Fibrosis Transmembrane Conductance Regulator |2 NLM | |
| 650 | 7 | |a 126880-72-6 |2 NLM | |
| 650 | 7 | |a ivacaftor |2 NLM | |
| 650 | 7 | |a 1Y740ILL1Z |2 NLM | |
| 650 | 7 | |a Receptor, Macrophage Colony-Stimulating Factor |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 700 | 1 | |a Jourdain, Marie Laure |e verfasserin |4 aut | |
| 700 | 1 | |a Abdallah, Dina |e verfasserin |4 aut | |
| 700 | 1 | |a Jacquot, Jacky |e verfasserin |4 aut | |
| 700 | 1 | |a Ronan, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a McCarthy, Yvonne |e verfasserin |4 aut | |
| 700 | 1 | |a Flanagan, Evelyn |e verfasserin |4 aut | |
| 700 | 1 | |a Plant, Barry |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of respiratory and critical care medicine |d 1994 |g 198(2018), 7 vom: 01. Okt., Seite 968-970 |w (DE-627)NLM074657305 |x 1535-4970 |7 nnns |
| 773 | 1 | 8 | |g volume:198 |g year:2018 |g number:7 |g day:01 |g month:10 |g pages:968-970 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1164/rccm.201803-0415LE |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 198 |j 2018 |e 7 |b 01 |c 10 |h 968-970 | ||